Q1 2017 Holdings
Filed 2017-05-15 | 106 holdings | $112.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $26.0M | 929,226 | 23.1% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $25.9M | 3,085,236 | 23.0% |
| Axogen Inc(AXGN) | COM | 05463X106 | $19.2M | 1,838,225 | 17.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $16.3M | 943,433 | 14.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $11.2M | 375,000 | 9.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $10.6M | 841,744 | 9.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $767.0K | 36,931 | 0.7% |
| Avexis Inc | COM | 05366U100 | $170.1K | 2,236,701 | 0.2% |
| Horizon Pharma PLC | SHS | G4617B105 | $161.8K | 10,944,988 | 0.1% |
| Nxstage Medical Inc | COM | 67072V103 | $100.5K | 3,744,151 | 0.1% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $83.3K | $90,100,000 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $81.7K | 1,203,000 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $79.6K | 2,042,224 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $61.4K | 1,743,229 | 0.1% |
| Isis Pharmaceuticals Inc del | NOTE 1.000%11/1 | 464337AJ3 | $60.2K | $62,500,000 | 0.1% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $56.9K | 1,451,301 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $54.6K | 1,365,000 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $52.6K | 318,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $51.5K | 425,545 | 0.0% |
| Endologix Inc | NOTE 2.250%12/1 | 29266SAA4 | $49.2K | $51,117,000 | 0.0% |
| Kempharm Inc | NOTE 5.500% 2/0 | 488445AB3 | $45.7K | $75,000,000 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $43.0K | 603,643 | 0.0% |
| Lannet Inc | COM | 516012101 | $41.4K | 1,853,896 | 0.0% |
| Endologix Inc | NOTE 3.250%11/0 | 29266SAB2 | $40.0K | $40,500,000 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $39.5K | $42,500,000 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $39.4K | 4,072,809 | 0.0% |
| Trinity Biotech Invt LTD | NOTE 4.000% 4/0 | 89643QAB4 | $38.9K | $48,000,000 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $38.2K | 1,709,400 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $37.8K | 402,998 | 0.0% |
| Molina Healthcare Inc | DBCV 1.625% 8/1 | 60855RAD2 | $37.1K | $35,000,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $36.1K | 795,743 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $34.1K | 267,000 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $34.0K | 229,000 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $33.6K | $27,600,000 | 0.0% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $32.5K | 728,949 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $32.2K | 2,299,046 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $31.9K | $22,385,000 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $31.8K | 2,640,609 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $31.7K | 753,300 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $30.7K | 1,284,758 | 0.0% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $29.6K | 355,957 | 0.0% |
| Universal Amern Corp New | COM | 91338E101 | $28.3K | 2,833,531 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $25.7K | 1,615,136 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $24.2K | 1,413,596 | 0.0% |
| Wright MED Group Inc | NOTE 2.000% 2/1 | 98235TAE7 | $24.0K | $20,025,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $23.9K | 1,403,653 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $23.5K | 845,746 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $22.4K | 259,768 | 0.0% |
| Advanced Accelerator Applic | SPONSORED ADS | 00790T100 | $20.8K | 523,023 | 0.0% |
| Fluidigm Corp del | NOTE 2.750% 2/0 | 34385PAA6 | $18.6K | $27,715,000 | 0.0% |